A61P 17 - Drugs for dermatological disorders

Patents for A61P 17 - Drugs for dermatological disorders (106,455)
10/2001
10/24/2001	CN1319092A Benzamide derivatives and their use as cytokine inhibitors
10/24/2001	CN1319088A Arylsulfonanilide ureas
10/24/2001	CN1319020A Extracts of feverfew (tanacetum parthenium) against inflammatory disorders
10/24/2001	CN1318408A External-use medicine for treating sore ulcer, wound, rheumatism and other diseases and its preparation
10/24/2001	CN1318404A Psoriasis treating medicine and its preparation
10/24/2001	CN1318397A Preparation of burn and scald treating medicine
10/24/2001	CN1318395A Dermatosis treating medicine and its preparation
10/24/2001	CN1318387A Wound-treating external-use medicine
10/24/2001	CN1318381A Compound wrinkle eliminating ointment and its preparation
10/24/2001	CN1318380A Compound spot-eliminating ointment and its preparation
10/24/2001	CN1318379A Leukoderma treating ointment and its preparation
10/24/2001	CN1318376A Compound psoriasis treating ointment and its preparation
10/24/2001	CN1073557C Vitamin-D amide derivatives
10/24/2001	CN1073434C Hair growth agent
10/24/2001	CN1073433C Medicine for psoriasis and preparing method thereof
10/23/2001	US6307089 Biphenyl butyric acids and their derivatives as inhibitors of matrix metalloproteinases
10/23/2001	US6307049 Useful for treating hair loss in mammals, including arresting and/or reversing hair loss and promoting hair growth.
10/23/2001	US6306887 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
10/23/2001	US6306881 Anti-inflammatory agents
10/23/2001	US6306879 Isotonic glucose solution
10/23/2001	US6306874 Enzyme inhibitors such as angiogenesis, cancer, tumor growth, atherosclerosis, age related macular degeneration, diabetic retinopathy, inflammatory diseases, and the like in mammals.
10/23/2001	US6306869 N-oxides
10/23/2001	US6306867 Treatment of respiratory system disorders, tumor necrosis factor and leukotrienes
10/23/2001	US6306863 Pyrrolo[3,4-d]pyrimidinone derivatives and their use as medicaments
10/23/2001	US6306854 Chemical compounds
10/23/2001	US6306848 Skin treatment
10/23/2001	US6306844 Use of 2α-methyl-19-nor-20(S)-1α, 25-dihydroxyvitamin D3 to increase bone strength
10/23/2001	US6306580 Preparation of human papillomavirus E1 having helicase activity and method therefor
10/23/2001	US6306398 Delipidating plant powder by extraction of powder with a solution containing organic solvent; separating powder from organic solvent; extracting delipidated powder with solvent or phosphate buffered saline; separation to obtain retentate
10/23/2001	CA2196096C Slimming composition containing a neuropeptide y receptor antagonist
10/23/2001	CA2043625C Skin preparations for external use
10/18/2001	WO2001077294A2 Hpv-specific short-mers
10/18/2001	WO2001077174A2 Human transporters and ion channels
10/18/2001	WO2001077169A2 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
10/18/2001	WO2001077146A2 Compounds and methods for modulating endothelial cell adhesion
10/18/2001	WO2001077137A1 Albumin fusion proteins
10/18/2001	WO2001077110A1 8-quinolinxanthine and 8-isoquinolinxanthine derivatives as pde 5 inhibitors
10/18/2001	WO2001077104A1 Bicyclic heterocylces, medicaments containing said compounds, the use thereof and method for producing them
10/18/2001	WO2001077101A1 Chemical compounds
10/18/2001	WO2001077100A2 Benzoamide piperidine compounds as substance p antagonists
10/18/2001	WO2001077093A1 Estrogen agonist/antagonist metabolites
10/18/2001	WO2001077087A1 Novel compounds
10/18/2001	WO2001077085A1 Quinazoline compounds
10/18/2001	WO2001077069A1 Naphthamide neurokinin antagonists for use as medicaments
10/18/2001	WO2001076644A2 Lipid-based systems for targeting diagnostic agents
10/18/2001	WO2001076605A1 Minoxidil-containing preparations
10/18/2001	WO2001076600A2 Inhibition of cytokine generation
10/18/2001	WO2001076589A1 Dermatological use and a dermatological preparation
10/18/2001	WO2001076572A2 Use of compatible solutes as substances having free radical scavenging properties
10/18/2001	WO2001076568A2 Use of 13-hode as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia
10/18/2001	WO2001076556A2 Lipid-based drug delivery systems against parasitic infections
10/18/2001	WO2001076555A2 Lipid-based drug delivery systems for topical application
10/18/2001	WO2001076542A1 Hair growth stimulant compositions
10/18/2001	WO2001076541A1 Hair growth stimulant compositions
10/18/2001	WO2001076537A1 Treatment of skin damage using polyenylphosphatidylcholine
10/18/2001	WO2001076530A2 Il-8 receptor antagonists
10/18/2001	WO2001052873A8 VEGETABLE OIL FOR PREPARING A COMPOSITION INHIBITING 5α- REDUCTASE ACTIVITY
10/18/2001	WO2001038548A3 Vectors capable of immortalizing non-dividing cells and cells immortalized with said vectors
10/18/2001	WO2001035933A3 A method of microencapsulation
10/18/2001	WO2001035901A3 Use of enzymes for skin expansion
10/18/2001	WO2000078299A3 Composition and method for preventing/reducing the severity of side effects of chemotherapy and/or radiation therapy
10/18/2001	WO2000039283A9 Use of cd40 engagement to alter t cell receptor usage
10/18/2001	US20010031777 Heterocyclic compounds and their therapeutic use
10/18/2001	US20010031766 Prostaglandin receptor ligands
10/18/2001	US20010031763 Substituted bis-acridines and related compounds as CCR5 receptor ligands, anti-inflammatory agents and anti-viral agents
10/18/2001	US20010031757 Administering compounds such as 3-(2-phenylethylamino)-6-methyl-1-(2-amino-6-methyl-5-methylene -carboxamidomethylpyridi nyl)-2-pyrazinone, N'-((1-(Aminoiminomethyl)4-piperidinyl) methyl)-N-(3,3- diphenylpropionyl)-L-proline amide
10/18/2001	US20010031744 Using mixture of plant extract and angiogenesis inhibitor
10/18/2001	US20010031735 Flavonoide esters and their use notably in cosmetics
10/18/2001	US20010031733 Compound B as angiogenic agent in combination with human growth factors
10/18/2001	US20010031285 Interleukin-4 production inhibitors
10/18/2001	US20010031273 Applying to skins
10/18/2001	US20010031260 Administering tumor necrosis factor antagonist; rheumatic diseases, skin disorders
10/18/2001	DE10016875A1 Stable, skin-compatible cosmetic or dermatological emulsions, comprises hydrophilic ethoxylated emulsifier, hydrophobic emulsifier formed from ethoxylated emulsifiers and stearic acid derivatives, and fatty alcohols
10/18/2001	DE10015955A1 Orally administered beauty-care composition, comprising confectionery obtained by treating pieces of peeled Aloe Vera leaves with sugar solution
10/18/2001	DE10013782A1 4-Fluoralkyl-2H-benzopyrane mit antiestrogener Wirksamkeit, Verfahren zu ihrer Herstellung, pharmazeutische Präparate, die diese enthalten sowie deren Verwendung zur Herstellung von Arzneimitteln 4-fluoroalkyl-2H-benzopyrans with antiestrogenic action, processes for their preparation, pharmaceutical compositions containing them and their use for the preparation of medicaments
10/18/2001	CA2406485A1 Hpv-specific short-mers
10/18/2001	CA2405912A1 Albumin fusion proteins
10/18/2001	CA2405476A1 Compounds and methods for modulating endothelial cell adhesion
10/18/2001	CA2405452A1 Hair growth stimulant compositions
10/18/2001	CA2405425A1 Dermatological preparations containing thyronine derivatives and uses thereof
10/18/2001	CA2405413A1 Inhibition of cytokine generation
10/18/2001	CA2405104A1 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
10/18/2001	CA2405089A1 Benzoamide piperidine containing compounds and related compounds
10/18/2001	CA2405070A1 Estrogen agonist/antagonist metabolites
10/18/2001	CA2404229A1 Human transporters and ion channels
10/18/2001	CA2403365A1 Quinazoline compounds
10/18/2001	CA2403012A1 Chemical compounds
10/18/2001	CA2400740A1 Treatment of skin damage using polyenylphosphatidylcholine
10/17/2001	EP1146046A2 Pyropheophorbides and their use in photodynamic therapy
10/17/2001	EP1145716A2 Therapeutic agent for the treatment of dermatitis
10/17/2001	EP1145710A1 Use of ascorbic acid derivatives for increasing epidermal ceramides synthesis
10/17/2001	EP1145709A1 Use of natural products to prepare cosmetic compositions
10/17/2001	EP1145706A1 Composition particularly for cosmetics comprising ascorbic acid in combination with an ascorbic acid derivative
10/17/2001	EP1145705A2 Composition, especially a cosmetic composition, containing a steroid and a 2-alkyl alkanol or ester thereof
10/17/2001	EP1144678A2 Susceptibility to psoriasis
10/17/2001	EP1144673A1 Methods of screening protease inhibitors, of inducing mice susceptible to hiv protease inhibitor-induced dyslipidemia, and genes associated therewith
10/17/2001	EP1144648A1 Cyclic nucleotide-associated proteins
10/17/2001	EP1144628A2 Human vanilloid receptor gene
10/17/2001	EP1144614A2 33 human secreted proteins
10/17/2001	EP1144592A2 Substrate for cell growth

1 ... 854 855 856 857 858 859 860 861 862 863 864 865 866 867 868 869 870 871 872 873 874 ... 1065